Ceribell CBLL
NASDAQ CBLL
$24.39 -0.47 (-1.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ceribell (CBLL) Debt Ratio (2023 - 2026)

Updated

Ceribell's Debt Ratio came in at 0.12 for Q2 2026, up 26.8% from 0.09 a year earlier and up 7.4% from the prior quarter.

Analysis

Ceribell (CBLL) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2025, Ceribell's Debt Ratio was 0.10, up 16.6% from FY2024.

  • Going back by year, Debt Ratio was 0.09 in FY2024 (-56.8%) and 0.20 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Debt Ratio since Q3 2024.
  • Year-over-year, Debt Ratio has increased for three consecutive quarters, with an average decline of 13.6% over the last five quarters.
  • Business Quant data shows CBLL's Debt Ratio at 0.11 (Q1 2026), 0.10 (Q4 2025) and 0.10 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 0.38
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 0.30
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 0.29
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 0.30
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 0.31
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 0.28
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 0.04
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 0.33
10 Ceribell 932.26 Mn 334.02 Mn 25.94 Mn 0.12
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.12
Mar 31, 2026 0.11
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.09
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.41
Dec 31, 2023 0.20
API Access

Ceribell Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CBLL&period=max&api_key=YOUR_API_KEY